Make Family Cancer Risk More Understandable
Cancer risk is influenced by more than age and lifestyle. In some families, inherited genetic variants may also play a role. Comprehensive hereditary cancer genetic testing helps assess lifetime risk for related cancers, especially for people with family cancer history, known familial variants or concerns about family risk.
Inherited Risk and Family History
Around 5-10% of cancers may be attributable to hereditary cancer. Women with breast cancer-related gene variants may have around 10 times higher breast cancer risk. Having one close relative with colorectal or gastric cancer may increase related cancer risk by about three times, and familial prostate cancer accounts for around 20% of all prostate cancers.
These findings should be interpreted by doctors together with personal background, family history and genetic results.
Scope of the Test
This comprehensive test targets 11 cancer types and analyses 123 genes associated with hereditary cancer. Coverage includes breast, ovarian, cervical, colorectal, gastric, prostate, skin, pancreatic, lung, kidney and endocrine cancers.
Depending on individual needs, specific tests such as BRCA-Pro, hereditary colorectal cancer, hereditary gastric cancer and hereditary prostate cancer genetic testing may also be considered separately.
Who May Consider It
People with family members affected by cancer: to understand whether they carry high-risk cancer-related variants. People with a known cancer gene mutation in the family: to assess whether they may carry the same variant. People already diagnosed with cancer: to understand whether hereditary factors may be involved and whether family members may need follow-up.
How Results Can Help
If a result suggests elevated risk, your doctor may discuss earlier screening, adjusted monitoring frequency, symptom awareness and options that may help reduce risk. The test itself is not a diagnosis; its purpose is to translate family history and genetic information into clearer medical follow-up.
Accuracy and Interpretation
Technical information indicates 99.9% accuracy for DNA sequencing, >99% accuracy for SNP and indel variant calling, and 100% variant annotation, with GenQA / UK NEQAS external quality assurance. Variant classification may change as medical knowledge develops, and results require clinical interpretation by medical professionals.
Enquire or Book
If you have a family history of cancer, a known familial mutation, or would like to know whether comprehensive hereditary cancer risk assessment is suitable for you, contact Well Clinic. Information is for health education and service introduction only and does not replace medical diagnosis or personalised advice.
Contact Us
WhatsApp / WeChat: +852 5292 0089
Address: Room B, 24/F, Lee Tung Building, 9 Li Yuen Street East, Central, Hong Kong